AG-LISDEXAMFETAMINE DIN 02537605
Health Canada record
| Active ingredient(s) | LISDEXAMFETAMINE DIMESYLATE 50 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | CONTROLLED DRUGS (CDSA I) |
| Class | Human |
| ATC | N06BA12 LISDEXAMFETAMINE |
| Original market date | 02-Jul-2026 |
| Current status date | 02-Jul-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Angita Pharma Inc. — licence 101870, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LISDEXAMFETAMINE DIMESYLATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02537621 | AG-LISDEXAMFETAMINE | ANGITA PHARMA INC. | Capsule | LISDEXAMFETAMINE DIMESYLATE 70 MG | Approved |
| 02537613 | AG-LISDEXAMFETAMINE | ANGITA PHARMA INC. | Capsule | LISDEXAMFETAMINE DIMESYLATE 60 MG | Marketed |
| 02537591 | AG-LISDEXAMFETAMINE | ANGITA PHARMA INC. | Capsule | LISDEXAMFETAMINE DIMESYLATE 40 MG | Marketed |
| 02537583 | AG-LISDEXAMFETAMINE | ANGITA PHARMA INC. | Capsule | LISDEXAMFETAMINE DIMESYLATE 30 MG | Marketed |
| 02537575 | AG-LISDEXAMFETAMINE | ANGITA PHARMA INC. | Capsule | LISDEXAMFETAMINE DIMESYLATE 20 MG | Marketed |
| 02537567 | AG-LISDEXAMFETAMINE | ANGITA PHARMA INC. | Capsule | LISDEXAMFETAMINE DIMESYLATE 10 MG | Marketed |
| 02494167 | APO-LISDEXAMFETAMINE | APOTEX INC | Capsule | LISDEXAMFETAMINE DIMESYLATE 70 MG | Approved |
| 02476983 | APO-LISDEXAMFETAMINE | APOTEX INC | Capsule | LISDEXAMFETAMINE DIMESYLATE 10 MG | Approved |
| 02468972 | APO-LISDEXAMFETAMINE | APOTEX INC | Capsule | LISDEXAMFETAMINE DIMESYLATE 20 MG | Approved |
| 02468980 | APO-LISDEXAMFETAMINE | APOTEX INC | Capsule | LISDEXAMFETAMINE DIMESYLATE 30 MG | Approved |
| 02468999 | APO-LISDEXAMFETAMINE | APOTEX INC | Capsule | LISDEXAMFETAMINE DIMESYLATE 40 MG | Approved |
| 02469006 | APO-LISDEXAMFETAMINE | APOTEX INC | Capsule | LISDEXAMFETAMINE DIMESYLATE 50 MG | Approved |
| 02469014 | APO-LISDEXAMFETAMINE | APOTEX INC | Capsule | LISDEXAMFETAMINE DIMESYLATE 60 MG | Approved |
| 02534444 | APO-LISDEXAMFETAMINE CHEWABLE TABLETS | APOTEX INC | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 10 MG | Marketed |
| 02534495 | APO-LISDEXAMFETAMINE CHEWABLE TABLETS | APOTEX INC | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 60 MG | Marketed |
| 02534487 | APO-LISDEXAMFETAMINE CHEWABLE TABLETS | APOTEX INC | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 50 MG | Marketed |
| 02534479 | APO-LISDEXAMFETAMINE CHEWABLE TABLETS | APOTEX INC | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 40 MG | Marketed |
| 02534460 | APO-LISDEXAMFETAMINE CHEWABLE TABLETS | APOTEX INC | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 30 MG | Marketed |
| 02534452 | APO-LISDEXAMFETAMINE CHEWABLE TABLETS | APOTEX INC | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 20 MG | Marketed |
| 02535181 | JAMP LISDEXAMFETAMINE | JAMP PHARMA CORPORATION | Capsule | LISDEXAMFETAMINE DIMESYLATE 70 MG | Marketed |
| 02535122 | JAMP LISDEXAMFETAMINE | JAMP PHARMA CORPORATION | Capsule | LISDEXAMFETAMINE DIMESYLATE 10 MG | Marketed |
| 02535173 | JAMP LISDEXAMFETAMINE | JAMP PHARMA CORPORATION | Capsule | LISDEXAMFETAMINE DIMESYLATE 60 MG | Marketed |
| 02535165 | JAMP LISDEXAMFETAMINE | JAMP PHARMA CORPORATION | Capsule | LISDEXAMFETAMINE DIMESYLATE 50 MG | Marketed |
| 02535157 | JAMP LISDEXAMFETAMINE | JAMP PHARMA CORPORATION | Capsule | LISDEXAMFETAMINE DIMESYLATE 40 MG | Marketed |
| 02535149 | JAMP LISDEXAMFETAMINE | JAMP PHARMA CORPORATION | Capsule | LISDEXAMFETAMINE DIMESYLATE 30 MG | Marketed |
| 02535130 | JAMP LISDEXAMFETAMINE | JAMP PHARMA CORPORATION | Capsule | LISDEXAMFETAMINE DIMESYLATE 20 MG | Marketed |
| 02546256 | SANDOZ LISDEXAMFETAMINE CAPSULES | SANDOZ CANADA INCORPORATED | Capsule | LISDEXAMFETAMINE DIMESYLATE 20 MG | Marketed |
| 02546248 | SANDOZ LISDEXAMFETAMINE CAPSULES | SANDOZ CANADA INCORPORATED | Capsule | LISDEXAMFETAMINE DIMESYLATE 10 MG | Marketed |
| 02533383 | TARO-LISDEXAMFETAMINE CHEWABLE TABLETS | TARO PHARMACEUTICALS INC | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 50 MG | Marketed |
| 02533375 | TARO-LISDEXAMFETAMINE CHEWABLE TABLETS | TARO PHARMACEUTICALS INC | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 40 MG | Marketed |
| 02533367 | TARO-LISDEXAMFETAMINE CHEWABLE TABLETS | TARO PHARMACEUTICALS INC | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 30 MG | Marketed |
| 02533359 | TARO-LISDEXAMFETAMINE CHEWABLE TABLETS | TARO PHARMACEUTICALS INC | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 20 MG | Marketed |
| 02533340 | TARO-LISDEXAMFETAMINE CHEWABLE TABLETS | TARO PHARMACEUTICALS INC | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 10 MG | Marketed |
| 02533391 | TARO-LISDEXAMFETAMINE CHEWABLE TABLETS | TARO PHARMACEUTICALS INC | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 60 MG | Marketed |
| 02535572 | TEVA-LISDEXAMFETAMINE | TEVA CANADA LIMITED | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 30 MG | Approved |
| 02535580 | TEVA-LISDEXAMFETAMINE | TEVA CANADA LIMITED | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 40 MG | Approved |
| 02535599 | TEVA-LISDEXAMFETAMINE | TEVA CANADA LIMITED | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 50 MG | Approved |
| 02535602 | TEVA-LISDEXAMFETAMINE | TEVA CANADA LIMITED | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 60 MG | Approved |
| 02545861 | TEVA-LISDEXAMFETAMINE | TEVA CANADA LIMITED | Capsule | LISDEXAMFETAMINE DIMESYLATE 10 MG | Marketed |
| 02545888 | TEVA-LISDEXAMFETAMINE | TEVA CANADA LIMITED | Capsule | LISDEXAMFETAMINE DIMESYLATE 20 MG | Marketed |
| 02545896 | TEVA-LISDEXAMFETAMINE | TEVA CANADA LIMITED | Capsule | LISDEXAMFETAMINE DIMESYLATE 30 MG | Marketed |
| 02545918 | TEVA-LISDEXAMFETAMINE | TEVA CANADA LIMITED | Capsule | LISDEXAMFETAMINE DIMESYLATE 40 MG | Marketed |
| 02545926 | TEVA-LISDEXAMFETAMINE | TEVA CANADA LIMITED | Capsule | LISDEXAMFETAMINE DIMESYLATE 50 MG | Marketed |
| 02545934 | TEVA-LISDEXAMFETAMINE | TEVA CANADA LIMITED | Capsule | LISDEXAMFETAMINE DIMESYLATE 60 MG | Marketed |
| 02545942 | TEVA-LISDEXAMFETAMINE | TEVA CANADA LIMITED | Capsule | LISDEXAMFETAMINE DIMESYLATE 70 MG | Marketed |
| 02535556 | TEVA-LISDEXAMFETAMINE | TEVA CANADA LIMITED | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 10 MG | Approved |
| 02535564 | TEVA-LISDEXAMFETAMINE | TEVA CANADA LIMITED | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 20 MG | Approved |
| 02490277 | VYVANSE | TAKEDA CANADA INC | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 60 MG | Marketed |
| 02490250 | VYVANSE | TAKEDA CANADA INC | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 40 MG | Marketed |
| 02490242 | VYVANSE | TAKEDA CANADA INC | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 30 MG | Marketed |
| 02490234 | VYVANSE | TAKEDA CANADA INC | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 20 MG | Marketed |
| 02490226 | VYVANSE | TAKEDA CANADA INC | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 10 MG | Marketed |
| 02458071 | VYVANSE | TAKEDA CANADA INC | Capsule | LISDEXAMFETAMINE DIMESYLATE 70 MG | Marketed |
| 02439603 | VYVANSE | TAKEDA CANADA INC | Capsule | LISDEXAMFETAMINE DIMESYLATE 10 MG | Marketed |
| 02347172 | VYVANSE | TAKEDA CANADA INC | Capsule | LISDEXAMFETAMINE DIMESYLATE 60 MG | Marketed |
| 02347164 | VYVANSE | TAKEDA CANADA INC | Capsule | LISDEXAMFETAMINE DIMESYLATE 40 MG | Marketed |
| 02347156 | VYVANSE | TAKEDA CANADA INC | Capsule | LISDEXAMFETAMINE DIMESYLATE 20 MG | Marketed |
| 02322978 | VYVANSE | TAKEDA CANADA INC | Capsule | LISDEXAMFETAMINE DIMESYLATE 50 MG | Marketed |
| 02322951 | VYVANSE | TAKEDA CANADA INC | Capsule | LISDEXAMFETAMINE DIMESYLATE 30 MG | Marketed |
| 02490269 | VYVANSE | TAKEDA CANADA INC | Tablet (Chewable) | LISDEXAMFETAMINE DIMESYLATE 50 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 33479 | 2024-06-21 | Abbreviated New Drug Submission (ANDS) | Administrative: Licensing Agreement between two manufacturers |
International API supply for LISDEXAMFETAMINE DIMESYLATE
10 active FDA Drug Master Files.
Request a quote for AG-LISDEXAMFETAMINE